Virco News
-
Market acceptance of virco®TYPE HIV-1 continues to grow, Virco BVBA to discontinue Antivirogram® for routine HIV market
Due to declining demand for the Antivirogram® in the US and other markets, Virco BVBA announced that as of April 26th, 2010, it will no longer offer this service for routine clinical use. The test will remain available for research and the drug discovery and development market. “Growing acceptance...Monday, 08 March 2010 @ 11:00
-
Virco Acquires LAB TRACKER™ HIV Electronic Medical Record Software System
Tibotec Virco Virology BVBA Acquires LAB TRACKER™ HIV Electronic Medical Record Software System from Ground Zero Software Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER™ HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER™ HIV is a full-service, scalable...Tuesday, 15 December 2009 @ 13:57
-
Correlating virtual phenotype-LM with an independent phenotypic assay (van Houtte et al) and recent enhancements to virco®TYPE HIV-1 analyses (Winters et al)
HIV-1 resistance testing has become the standard-of-care for managing treatment-experienced patients and is increasingly recommended for treatment-naïve patients. The two standard methods for resistance testing are genotyping, which is generally used in treatment-naïve patients and where relatively simple resistance patterns are expected, and phenotyping, which is more commonly used in...Thursday, 05 November 2009 @ 13:20
-
Virco BVBA in a collaboration with German KompetenzNetz HIV/AIDS to enhance HIV drug resistance interpretation
Focused relationship will allow both infrastructure development and research to gain better understanding of HIV drug resistance and patient outcomes Virco BVBA is pleased to announce the signing of their first collaboration agreement with KompetenzNetz HIV/AIDS, a German research network for HIV/AIDS representing a cohort of over 8,000 HIV patients...Tuesday, 28 July 2009 @ 16:35
-
NEW ! Clinical Cases in HIV Resistance
Volume 1 Number 1 click here...Wednesday, 15 July 2009 @ 13:50
-
Virco collaboration poster wins award at IHDRW
The Poster "Phenotypic Data to Guide Selection of RTI in Second Line Therapy following Extended Virological Failure in Uganda", with authors from the MRC, several African centers, and Virco, received one of two awards for best posters at the IHDRW awards dinner. The first author, Dr N Ndembi, from the...Tuesday, 16 June 2009 @ 15:29
-
Virco signs Hepatitis C licensing agreement with Siemens Healthcare Diagnostics Inc.
Virco BVBA signs Hepatitis C licensing agreement with Siemens Healthcare Diagnostics Inc. Mechelen, Belgium, 28 May 2009: Virco BVBA has today signed a global research and development, non-exclusive licensing agreement with Siemens Healthcare Diagnostics Inc (NY, USA). Under this agreement Siemens is providing Virco a license which will enable...Thursday, 04 June 2009 @ 16:10
-
Striking decrease in multi-class resistance
Mechelen, Belgium. April 27, 2009 Prakash Sista and colleagues at Virco recently published a report in the Journal of Clinical Virology on the prevalence of calculated phenotypic resistance in the >240,000 samples submitted to Virco for routine clinical testing between 1998 and June of 2007. They report a striking decrease...Thursday, 04 June 2009 @ 15:46
-
Virco Lab, Inc. enters into Collaboration with SmartGene, Inc.
Mechelen, Belgium. April 20, 2009 Virco Lab, Inc. is pleased to announce a US collaboration with SmartGene, Inc. a provider of novel services for the management and analysis of genetic data to provide laboratories and physicians with greater insight into HIV drug resistance and to transfer the ordering, viewing and...Tuesday, 02 June 2009 @ 15:57
-
Virco in Treat Asia Initiative
Mechelen, Belgium. March 3, 2009 There are more than 5 million people living with HIV across Asia and the Pacific, including 150,000 children. Each year more than 500,000 people are newly diagnosed with HIV in the region and more than 300,000 die from AIDS-related complications. TREAT Asia (Therapeutics, Research, Education...Wednesday, 04 March 2009 @ 16:01